| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fusion Pharmaceuticals Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $2.03 | 04 Jun 2024 | Direct |
| Fusion Pharmaceuticals Inc. | Chief Financial Officer | Restricted Stock Units | 0 | $0 | $2.03 | 04 Jun 2024 | Direct |
| Centessa Pharmaceuticals plc | Chief Financial Officer | Share Option (right to buy) | 250,000 | 03 Feb 2025 | Direct | ||
| Fusion Pharmaceuticals Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 04 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | 03 Feb 2025 | 1 | $0 | 4 | Chief Financial Officer | 04 Feb 2025, 16:57 |
| CNTA | Centessa Pharmaceuticals plc | 01 Jul 2024 | 1 | $0 | 4 | Chief Financial Officer | 02 Jul 2024, 16:30 |
| CNTA | Centessa Pharmaceuticals plc | 10 Jun 2024 | 0 | $0 | 3 | Chief Financial Officer | 17 Jun 2024, 20:49 |
| FUSN | Fusion Pharmaceuticals Inc. | 04 Jun 2024 | 10 | $0 | 4 | Chief Financial Officer | 04 Jun 2024, 17:26 |
| FUSN | Fusion Pharmaceuticals Inc. | 04 Jan 2024 | 2 | $0 | 4 | Chief Financial Officer | 05 Jan 2024, 08:52 |
| FUSN | Fusion Pharmaceuticals Inc. | 05 Jan 2023 | 1 | $0 | 4 | Chief Financial Officer | 09 Jan 2023, 05:44 |
| FUSN | Fusion Pharmaceuticals Inc. | 01 Feb 2022 | 2 | $0 | 4 | Chief Financial Officer | 03 Feb 2022, 18:37 |